Correction: Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting (PLoS ONE (2013) 8:11 (e79452) DOI: 10.1371/journal.pone.0079452);Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Lee, Chien Hsing ^a   Shieh, Yi Shing ^a   Tsai, Chien Sung ^a   Hung, Yi Jen ^a   Tsai, Yi Ting ^a   Lin, Chih Yuan ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; GROWTH ARREST SPECIFIC PROTEIN 6; PROTEIN AXL; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AGED; AORTA INJURY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURGICAL MORTALITY;

AGED; AORTA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RISK FACTORS;

EID: 84890759247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175754     Document Type: Erratum

References (40)

1. Schneider C, King RM, Philipson L (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell 54: 787-793.
2. Stitt TN, Conn G, Gore M, Lai C, Bruno J, et al. (1995) The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 80: 661-670.
3. Nyberg P, He X, Hardig Y, Dahlback B, Garcia de Frutos P (1997) Stimulation of Sky tyrosine phosphorylation by bovine protein S - domains involved in the receptor-ligand interaction. Eur J Biochem 246: 147-154. (Pubitemid 27229681)
4. Hafizi S, Dahlback B (2006) Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 273: 5231-5244. (Pubitemid 44772384)
5. Fernandez-Fernandez L, Bellido-Martin L, Garcia de Frutos P (2008) Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost 100: 604-610.
6. Melaragno MG, Wuthrich DA, Poppa V, Gill D, Lindner V, et al. (1998) Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ Res 83: 697-704. (Pubitemid 28462783)
7. Nakano T, Kawamoto K, Higashino K, Arita H (1996) Prevention of growth arrest-induced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, gas6. FEBS Lett 387: 78-80. (Pubitemid 26170742)
8. Fridell YW, Villa J Jr, Attar EC, Liu ET (1998) GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem 273: 7123-7126. (Pubitemid 28160384)
9. Korshunov VA, Mohan AM, Georger MA, Berk BC (2006) Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 98: 1446-1452. (Pubitemid 43948070)
10. Ait-Oufella H, Pouresmail V, Simon T, Blanc-Brude O, Kinugawa K, et al. (2008) Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol 28: 1429-1431.
11. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I (2008) Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol 28: 1421-1428.
12. Lutgens E, Tjwa M, Garcia de Frutos P, Wijnands E, Beckers L, et al. (2008) Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J Pathol 216: 55-63.
13. Cavet ME, Smolock EM, Ozturk OH, World C, Pang J, et al. (2008) Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28: 886-891. (Pubitemid 351544103)
14. Alciato F, Sainaghi PP, Sola D, Castello L, Avanzi GC (2010) TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J Leukoc Biol 87: 869-875.
15. Avanzi GC, Gallicchio M, Bottarel F, Gammaitoni L, Cavalloni G, et al. (1998) GAS6 inhibits granulocyte adhesion to endothelial cells. Blood 91: 2334-2340. (Pubitemid 28155506)
16. Tjwa M, Bellido-Martin L, Lin Y, Lutgens E, Plaisance S, et al. (2008) Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 111: 4096-4105.
17. Clauser S, Meilhac O, Bieche I, Raynal P, Bruneval P, et al. (2012) Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques. Thromb Haemost 107: 140-149.
18. Taggart DP (2005) Surgery is the best intervention for severe coronary artery disease. BMJ 330: 785-786.
19. Malarstig A, Lindahl B, Wallentin L, Siegbahn A (2006) Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome. Arterioscler Thromb Vasc Biol 26: 1667-1673. (Pubitemid 44288999)
20. Son BK, Kozaki K, Iijima K, Eto M, Kojima T, et al. (2006) Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res 98: 1024-1031.
21. Jiang L, Liu CY, Yang QF, Wang P, Zhang W (2009) Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Am J Clin Pathol 131: 738-743.
22. Hung YJ, Lee CH, Chu NF, Shieh YS (2010) Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care 33: 1840-1844.
23. Ekman C, Site DF, Gottsater A, Lindblad B, Dahlback B (2010) Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms. Clin Biochem 43: 110-114.
24. Ekman C, Gottsater A, Lindblad B, Dahlback B (2010) Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin Biochem 43: 873-876.
25. Ekman C, Stenhoff J, Dahlback B (2010) Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 8: 838-844.
26. Hsiao FC, Lin YF, Hsieh PS, Chu NF, Shieh YS, et al. (2013) Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents. J Clin Endocrinol Metab 98: E267-274.
27. Korshunov VA, Daul M, Massett MP, Berk BC (2007) Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension. Hypertension 50: 1057-1062. (Pubitemid 350172927)
28. D'Arcangelo D, Gaetano C, Capogrossi MC (2002) Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res 91: e4-12.
29. Konishi A, Aizawa T, Mohan A, Korshunov VA, Berk BC (2004) Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J Biol Chem 279: 28766-28770. (Pubitemid 38900161)
30. Son BK, Kozaki K, Iijima K, Eto M, Nakano T, et al. (2007) Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol 556: 1-8. (Pubitemid 46073988)
31. Kim H, Kim HJ, Lee K, Kim JM, Kim HS, et al. (2012) alpha-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J Cell Mol Med 16: 273-286.
32. Lu Q, Lemke G (2001) Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293: 306-311. (Pubitemid 32694748)
33. Lemke G, Lu Q (2003) Macrophage regulation by Tyro 3 family receptors. Curr Opin Immunol 15: 31-36. (Pubitemid 35454189)
34. Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288: 2579-2588. (Pubitemid 35386893)
35. Kobayashi KJ, Williams JA, Nwakanma LU, Weiss ES, Gott VL, et al. (2009) EuroSCORE predicts short- and mid-term mortality in combined aortic valve replacement and coronary artery bypass patients. J Card Surg 24: 637-643.
36. Metzler B, Winkler B (2012) SYNTAX, STS and EuroSCORE - how good are they for risk estimation in atherosclerotic heart disease? Thromb Haemost 108: 1065-1071.
37. Gibot S, Massin F, Cravoisy A, Dupays R, Barraud D, et al. (2007) Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit Care 11: R8.
38. Kim HA, Nam JY, Jeon JY, An JM, Jung JY, et al. (2013) Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus. J Clin Immunol 33: 143-150.
39. Gheita TA, Bassyouni IH, Bassyouni RH (2012) Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behcets disease. J Clin Immunol 32: 1279-1286.
40. Hurtado B, Munoz X, Recarte-Pelz P, Garcia N, Luque A, et al. (2011) Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques. Thromb Haemost 105: 873-882.